Fatal Cache Valley virus meningoencephalitis associated with rituximab maintenance therapy

Am J Hematol. 2018 Aug;93(4):590-594. doi: 10.1002/ajh.25024. Epub 2018 Jan 25.

Authors

Yuanquan Yang¹, Jingxin Qiu², Abigail Snyder-Keller³, Yongping Wu³, Shufeng Sun³, Haixin Sui³, Amy B Dean³, Laura Kramer³, Francisco Hernandez-Ilizaliturri¹

Affiliations

¹ Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
² Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York.
³ Wadsworth Center, New York State Department of Health, Albany, New York.

No abstract available

Publication types

Case Reports
Research Support, N.I.H., Extramural
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Atrophy
Autoimmune Diseases of the Nervous System / diagnosis
B-Lymphocytes / drug effects
B-Lymphocytes / immunology
B-Lymphocytes / pathology
Bendamustine Hydrochloride / administration & dosage
Brain / pathology
Bunyamwera virus / isolation & purification*
Bunyaviridae Infections / diagnosis
Bunyaviridae Infections / diagnostic imaging
Bunyaviridae Infections / etiology*
Bunyaviridae Infections / virology
Diagnosis, Differential
Fatal Outcome
Gliosis / diagnostic imaging
Gliosis / etiology
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Magnetic Resonance Imaging
Maintenance Chemotherapy / adverse effects
Male
Meningoencephalitis / diagnosis
Meningoencephalitis / diagnostic imaging
Meningoencephalitis / etiology*
Meningoencephalitis / virology
Middle Aged
Paraneoplastic Syndromes, Nervous System / diagnosis
Rituximab / administration & dosage
Rituximab / adverse effects*

Substances

Rituximab
Bendamustine Hydrochloride

Grants and funding